Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
Clinical trial NCT01524289 · COMPLETED
Trial details
- NCT number
- NCT01524289
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-03
- Primary completion
- 2014-02-12
- Enrollment
- 306
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.